Cargando…
Schisandrin B: A Double-Edged Sword in Nonalcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease (NAFLD) is a spectrum of liver lesions ranging from hepatic steatosis, nonalcoholic steatohepatitis, hepatic cirrhosis, and hepatocellular carcinoma. The high global prevalence of NAFLD has underlined the important public health implications of this disease. The path...
Autores principales: | Leong, Pou Kuan, Ko, Kam Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5101399/ https://www.ncbi.nlm.nih.gov/pubmed/27847552 http://dx.doi.org/10.1155/2016/6171658 |
Ejemplares similares
-
Differential Action between Schisandrin A and Schisandrin B in Eliciting an Anti-Inflammatory Action: The Depletion of Reduced Glutathione and the Induction of an Antioxidant Response
por: Leong, Pou Kuan, et al.
Publicado: (2016) -
CDKN1A: A double-edged sword in fatty liver?
por: Valenti, Luca, et al.
Publicado: (2014) -
Noninvasive markers: a double-edged sword that stratifies nonalcoholic steatohepatitis
por: Chung, Goh Eun, et al.
Publicado: (2013) -
Inflammasome: A Double-Edged Sword in Liver Diseases
por: Luan, Jingyun, et al.
Publicado: (2018) -
Double-edged sword.
Publicado: (1994)